Nurse management of trastuzumab for patients with breast cancer
Edward Pace Clinical nurse specialist – Chemotherapy, Plymouth Hospitals NHS Trust, Derriford Hospital, Plymouth
Pauline McIlroy Breast clinical nurse specialist, Beatson Oncology Centre, Glasgow
Modern techniques that enable the molecular characterisation of cancerous tissue have lead to the development of new and more specific therapies. Trastuzumab (Herceptin), a monoclonal antibody drug for the treatment of breast cancer, is one such therapy. Now that trastuzumab is approved for use in the UK, this article will discuss the nursing management of its infusion, possible side effects, aftercare and the psychological needs of the patient being treated with this new drug.
Cancer Nursing Practice. 3, 1,35-39. doi: 10.7748/cnp2004.02.3.1.35.c108